Rigel Pharmaceuticals, Inc. (RIGL)

Last Closing Price: 40.74 (2025-08-25)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Rigel Pharmaceuticals, Inc. (RIGL) had Income after Taxes of $59.61M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$101.69M
$59.61M
$4.50M
$97.18M
$40.58M
$61.10M
$-1.12M
$59.98M
$59.98M
Income after Taxes
$59.61M
$59.61M
$59.61M
$59.61M
$61.10M
$61.46M
17.89M
18.16M
$3.33
$3.28
Balance Sheet Financials
$175.39M
$0.06M
$31.34M
$206.74M
$86.64M
$37.45M
$38.17M
$124.80M
$81.93M
$56.01M
$81.93M
17.94M
Cash Flow Statement Financials
$29.64M
$-33.83M
$0.90M
$56.75M
$53.46M
$-3.28M
$6.60M
--
--
Fundamental Metrics & Ratios
2.02
--
--
0.31
0.73
95.57%
60.09%
60.09%
--
58.99%
58.63%
$29.64M
--
--
--
0.49
0.43
2.55
35.32
72.76%
106.43%
28.84%
49.93%
$4.57
$1.63
$1.63